CellaVision AB (publ)
CellaVision AB (publ) (CLVSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLVSF · as of Jun 9, 2026
Key Statistics
Explore CellaVision AB (publ) Data
clvsf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
clvsf competitorsCLVSF
AVNBF
BJTRF
BOIRF
CALZF
FDMDFStock Performance
Full HistoryAbout CellaVision AB (publ)
CellaVision AB (publ) a company established in Lund, Sweden, in 1994, specializes in the development and distribution of digital analytical solutions for blood and body fluid samples. Their offerings…
what is cellavision ab (publ) · clvsf stock overview · cellavision ab (publ) company profile · who is cellavision ab (publ) ceo · clvsf OTC · cellavision ab (publ) headquarters · cellavision ab (publ) business segments
About Stock Overview & Key Data
CellaVision AB (publ) (CLVSF) is a Healthcare company in the Medical - Devices industry, listed on OTC since Aug 20, 2013. As of the latest trading session, CLVSF stock price is $13.49, with a market capitalization of $321.8M. The stock has returned -30.03% over the past 12 months and -19.85% year-to-date.
According to 1 Wall Street analysts, the consensus rating for CellaVision AB (publ) stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, CellaVision AB (publ) reported revenue of $759.0M and net income of $153.1M. For detailed data — including CellaVision AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CellaVision AB (publ) (CLVSF) stock price is $13.49. The stock is traded on OTC under the ticker symbol CLVSF. The 52-week range is $13.49 – $19.28.